Loading
JPXConsumer DefensivePackaged Foods
Latest quote
¥864
−¥2.00 · -0.23%
AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business. The Healthcare segment manufactures, sells, and supplies OEM health foods, such as tablets, capsules, granules, soft drinks, and jelly; and cosmetics, including skin care and hair care products. This segment also operates as an advertising agency focused on planning and producing health information programs, and publishing health information magazines. The Pharmaceutical segment manufactures and sells Chinese herbal medicine, over-the-counter medicines, and generic medicines. The Department Store segment engages in the wholesale of watches, jewelry, and precious metal products. The Food and Beverage segment operates restaurants. The Other Business segment engages in the real estate buying, selling, management, rental, and intermediary business; construction industry; tourism, travel and hotel industry; and school lunch business. AFC-HD AMS Life Science Co., Ltd. was founded in 1969 and is headquartered in Shizuoka, Japan.
Latest quote
¥864
−¥2.00 · -0.23%
Regular session · JST · Market data may be delayed.
AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business. The Healthcare segment manufactures, sells, and supplies OEM health foods, such as tablets, capsules, granules, soft drinks, and jelly; and cosmetics, including skin care and hair care products. This segment also operates as an advertising agency focused on planning and producing health information programs, and publishing health information magazines. The Pharmaceutical segment manufactures and sells Chinese herbal medicine, over-the-counter medicines, and generic medicines. The Department Store segment engages in the wholesale of watches, jewelry, and precious metal products. The Food and Beverage segment operates restaurants. The Other Business segment engages in the real estate buying, selling, management, rental, and intermediary business; construction industry; tourism, travel and hotel industry; and school lunch business. AFC-HD AMS Life Science Co., Ltd. was founded in 1969 and is headquartered in Shizuoka, Japan.
Day range
Current ¥864
52-week range
Current ¥864
Regular session · JST · Market data may be delayed.
AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business. The Healthcare segment manufactures, sells, and supplies OEM health foods, such as tablets, capsules, granules, soft drinks, and jelly; and cosmetics, including skin care and hair care products. This segment also operates as an advertising agency focused on planning and producing health information programs, and publishing health information magazines. The Pharmaceutical segment manufactures and sells Chinese herbal medicine, over-the-counter medicines, and generic medicines. The Department Store segment engages in the wholesale of watches, jewelry, and precious metal products. The Food and Beverage segment operates restaurants. The Other Business segment engages in the real estate buying, selling, management, rental, and intermediary business; construction industry; tourism, travel and hotel industry; and school lunch business. AFC-HD AMS Life Science Co., Ltd. was founded in 1969 and is headquartered in Shizuoka, Japan.
Day range
Current ¥864
52-week range
Current ¥864
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 32.66B JPY | 30.19B JPY | 25.58B JPY | 23B JPY | 22.37B JPY |
| Cost of goods sold | 21.68B JPY | 19.69B JPY | 16.26B JPY | 14.42B JPY | 15.5B JPY |
| Gross profit | 10.97B JPY | 10.49B JPY | 9.32B JPY | 8.58B JPY | 6.87B JPY |
| Research and development | 143.12M JPY | 148M JPY | 145.06M JPY | 153.03M JPY | 163.7M JPY |
| Selling, general, and administrative | 8.39B JPY | 8.35B JPY | 7.53B JPY | 7.26B JPY | 4.42B JPY |
| Operating expenses | 8.59B JPY | 8.58B JPY | 7.69B JPY | 7.57B JPY | 4.62B JPY |
| Interest income | 10.78M JPY | 2.46M JPY | 4.19M JPY | 4.06M JPY | 3.47M JPY |
| Interest expense | 201.23M JPY | 101.27M JPY | 57.56M JPY | 57.59M JPY | 50.04M JPY |
| Depreciation and amortization | 1.4B JPY | 1.09B JPY | 984M JPY | 1.01B JPY | 649.88M JPY |
| Operating income | 2.38B JPY | 1.92B JPY | 1.64B JPY | 1.02B JPY | 2.25B JPY |
| Net income | 1.45B JPY | 1.25B JPY | 1.1B JPY | 735.35M JPY | 1.5B JPY |
Company facts updated Sep 6, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
¥34.00
2025 complete year+23.6% since 2021
2026 partial: ¥40.00
¥27.50
2,021
¥30.00
2,022
¥27.50
2,023
¥30.00
2,024
¥34.00
2,025
¥40.00
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Aug 28, 2026 | ¥22.00Semi-Annual | Aug 31, 2026 | Aug 28, 2026 |
Dividend | Feb 26, 2026 | ¥18.00Semi-Annual | Feb 28, 2026 | May 21, 2026 |
Dividend | Aug 28, 2025 | ¥18.00Semi-Annual | Aug 31, 2025 | Nov 28, 2025 |
Dividend | Feb 27, 2025 | ¥16.00Semi-Annual | Feb 28, 2025 | May 19, 2025 |
Dividend | Aug 29, 2024 | ¥15.00Semi-Annual | Aug 31, 2024 | Nov 27, 2024 |
Dividend | Feb 28, 2024 | ¥15.00Semi-Annual | Feb 29, 2024 | May 17, 2024 |
Ex-dividend Aug 28, 2026
¥22.00
Semi-Annual
Record Aug 31, 2026 · Payment Aug 28, 2026
Ex-dividend Feb 26, 2026
¥18.00
Semi-Annual
Record Feb 28, 2026 · Payment May 21, 2026
Ex-dividend Aug 28, 2025
¥18.00
Semi-Annual
Record Aug 31, 2025 · Payment Nov 28, 2025
Ex-dividend Feb 27, 2025
¥16.00
Semi-Annual
Record Feb 28, 2025 · Payment May 19, 2025
Ex-dividend Aug 29, 2024
¥15.00
Semi-Annual
Record Aug 31, 2024 · Payment Nov 27, 2024
Ex-dividend Feb 28, 2024
¥15.00
Semi-Annual
Record Feb 29, 2024 · Payment May 17, 2024
Funds reporting this stock among their holdings, ordered by reported position size.
Avantis International Small Cap Value ETFAVDV86.31K—20.38B USD0.36%$113.75+0.07%
Dimensional - International Core Equity 2 ETFDFIC56.84K0.00%15.37B USD0.22%$39.475-0.01%
Dimensional - International Small Cap ETFDFIS45.69K0.00%5.86B USD0.39%$37.67+0.13%
Dimensional World ex U.S. Core Equity 2 ETFDFAX38.61K0.00%12.55B USD0.28%$38.61+0.44%
Avantis International Equity ETFAVDE4.45K—19.08B USD0.23%$94.51+0.01%Avantis International Small Cap Value ETFAVDVDimensional - International Core Equity 2 ETFDFICDimensional - International Small Cap ETFDFISDimensional World ex U.S. Core Equity 2 ETFDFAXAvantis International Equity ETFAVDEAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
